Henry H. Armstrong Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.38M Sell
94,280
-5,329
-5% -$430K 0.71% 15
2026
Q1
$8.63M Sell
99,609
-320
-0.3% -$30.7K 0.88% 14
2025
Q4
$9.6M Sell
99,929
-8,198
-8% -$796K 0.89% 12
2025
Q3
$10.3M Sell
108,127
-1,215
-1% -$112K 0.93% 12
2025
Q2
$9.53M Sell
109,342
-11,238
-9% -$953K 0.9% 12
2025
Q1
$10.8M Sell
120,580
-2,164
-2% -$194K 1.05% 11
2024
Q4
$9.8M Sell
122,744
-15,585
-11% -$1.35M 0.98% 11
2024
Q3
$12.5M Sell
138,329
-8,374
-6% -$704K 1.19% 11
2024
Q2
$11.5M Sell
146,703
-3,820
-3% -$313K 1.15% 12
2024
Q1
$13.1M Sell
150,523
-915
-0.6% -$78.1K 1.28% 10
2023
Q4
$12.5M Sell
151,438
-20,835
-12% -$1.59M 1.33% 12
2023
Q3
$13.5M Sell
172,273
-5,229
-3% -$438K 1.54% 9
2023
Q2
$15.6M Sell
177,502
-11,518
-6% -$992K 1.73% 8
2023
Q1
$15.2M Sell
189,020
-16,143
-8% -$1.32M 1.86% 8
2022
Q4
$15.9M Sell
205,163
-5,752
-3% -$466K 1.98% 7
2022
Q3
$17M Buy
210,915
+362
+0.2% +$32.5K 2.31% 7
2022
Q2
$18.9M Buy
210,553
+252
+0.1% +$25.5K 2.38% 7
2022
Q1
$23.3M Sell
210,301
-1,745
-0.8% -$184K 2.46% 8
2021
Q4
$21.9M Sell
212,046
-2,422
-1% -$280K 2.3% 8
2021
Q3
$26.9M Sell
214,468
-114
-0.1% -$14.8K 3.11% 7
2021
Q2
$26.6M Sell
214,582
-980
-0.5% -$123K 3.06% 8
2021
Q1
$25.5M Sell
215,562
-21
-0% -$2.46K 3.14% 8
2020
Q4
$25.3M Buy
215,583
+2,076
+1% +$229K 3.33% 7
2020
Q3
$22.2M Sell
213,507
-2,139
-1% -$215K 3.08% 8
2020
Q2
$19.8M Sell
215,646
-2,888
-1% -$277K 2.96% 8
2020
Q1
$19.7M Buy
218,534
+2,676
+1% +$285K 3.27% 8
2019
Q4
$24.5M Buy
215,858
+1,690
+0.8% +$185K 3.53% 8
2019
Q3
$23.3M Buy
214,168
+1,585
+0.7% +$165K 3.82% 8
2019
Q2
$20.7K Sell
212,583
-23,280
-10% -$2.13M 2.83% 10
2019
Q1
$21.5M Buy
235,863
+3,596
+2% +$322K 3.31% 9
2018
Q4
$21.1M Buy
232,267
+15,005
+7% +$1.4M 3.47% 9
2018
Q3
$21.4M Buy
217,262
+10,045
+5% +$929K 3.28% 9
2018
Q2
$17.7M Buy
207,217
+2,585
+1% +$216K 3.03% 9
2018
Q1
$16.5M Buy
204,632
+9,795
+5% +$808K 2.74% 9
2017
Q4
$15.7M Buy
194,837
+10,280
+6% +$823K 2.65% 9
2017
Q3
$14.4M Buy
184,557
+21,060
+13% +$1.75M 2.58% 9
2017
Q2
$14.5M Buy
163,497
+18,110
+12% +$1.53M 2.77% 9
2017
Q1
$11.7M Buy
145,387
+10,520
+8% +$822K 2.22% 10
2016
Q4
$9.61M Buy
134,867
+2,855
+2% +$224K 1.99% 10
2016
Q3
$11.4M Sell
132,012
-69
-0.1% -$6.01K 2.19% 11
2016
Q2
$11.5M Buy
132,081
+8,086
+7% +$654K 2.3% 11
2016
Q1
$9.3M Sell
123,995
-6,533
-5% -$492K 1.92% 11
2015
Q4
$10M Sell
130,528
-2,600
-2% -$196K 1.97% 13
2015
Q3
$8.91M Sell
133,128
-6,182
-4% -$455K 1.83% 13
2015
Q2
$10.3M Buy
139,310
+565
+0.4% +$43.2K 2.5% 11
2015
Q1
$10.8M Buy
138,745
+640
+0.5% +$48.5K 2.39% 11
2014
Q4
$9.97M Sell
138,105
-2,783
-2% -$193K 2.16% 12
2014
Q3
$8.73M Sell
140,888
-1,150
-0.8% -$73.1K 2% 12
2014
Q2
$9.06M Buy
142,038
+900
+0.6% +$54.7K 2.16% 12
2014
Q1
$8.69M Sell
141,138
-450
-0.3% -$26.2K 2.15% 11
2013
Q4
$8.13M Sell
141,588
-1,700
-1% -$96.4K 1.68% 11
2013
Q3
$7.63M Sell
143,288
-1,234
-0.9% -$66.4K 2.06% 11
2013
Q2
$7.44M Buy
+144,522
New +$7.14M 2.02% 12

Other funds holding MDT

Henry H. Armstrong Associates's MDT Position: Q2 2026 in Review

Henry H. Armstrong Associates reduced its Medtronic (MDT) stake by 5.3% in Q2 2026, selling an estimated $430K and leaving 94,280 shares worth $7.38M. The position accounts for 0.71% of the portfolio, ranked #15.

Henry H. Armstrong Associates first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $26.9M in Q3 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Henry H. Armstrong Associates held 94,280 shares of Medtronic worth $7.38M as of Q2 2026.
  • Henry H. Armstrong Associates sold 5,329 Medtronic shares in Q2 2026, an estimated $430K.
  • Medtronic made up 0.71% of Henry H. Armstrong Associates's portfolio in Q2 2026, its #15 holding.
  • Henry H. Armstrong Associates first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Henry H. Armstrong Associates's Medtronic position peaked at $26.9M in Q3 2021.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Henry H. Armstrong Associates's 13F filing for Q2 2026, filed 7 Jul 2026.